Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Biogen
BIIB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$194.54
-1.27
-0.65%
Last update: 2:46 PM
15 minutes delayed
Get Report
Comment
Biogen (BIIB) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Biogen (NASDAQ:BIIB) Stock
Biogen Stock (NASDAQ: BIIB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, September 24, 2024
Needham Reiterates Buy on Biogen, Maintains $...
Benzinga Newsdesk
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
Vandana Singh
UCB And Biogen Report Results In Phase 3 Lupu...
Benzinga Newsdesk
Monday, September 23, 2024
Forecasting The Future: 20 Analyst Projections For Biogen
Benzinga Insights
Wedbush Maintains Neutral on Biogen, Lowers P...
Benzinga Newsdesk
Thursday, September 19, 2024
RBC Capital Reiterates Outperform on Biogen, ...
Benzinga Newsdesk
Wednesday, September 18, 2024
Biogen Executive Says Company Expects Immunog...
Benzinga Newsdesk
Tuesday, September 17, 2024
Lilly Gets FDA Approval for Eczema Drug Ebglyss
Zacks
Biogen's New Drug Submission For Omaveloxolon...
Benzinga Newsdesk
Wednesday, September 11, 2024
Bio-Thera Solutions, Biogen Publish Phase 3 C...
Benzinga Newsdesk
Tuesday, September 10, 2024
C4 Therapeutics Has Delivered A Second Develo...
Benzinga Newsdesk
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
Benzinga Neuro
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
Benzinga Neuro
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Bi...
Benzinga Newsdesk
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
Vandana Singh
Wednesday, September 04, 2024
Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
Vandana Singh
Key Takeaways From Biogen Analyst Ratings
Benzinga Insights
Biogen Announces Data for Higher Dose Nusiner...
Benzinga Newsdesk
Needham Reiterates Buy on Biogen, Maintains $...
Benzinga Newsdesk
Wednesday, August 28, 2024
Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker
Benzinga Neuro
Tuesday, August 27, 2024
Chinese E-Commerce Giant Drops 35% In 2 Days, But Analysts See 92% Upside Potential
Piero Cingari
Monday, August 26, 2024
Eli Lilly's Alzheimer's Drug Faces UK Agency Block After Biogen's Medicine Rejection Over Cost, Safety
Vandana Singh
Thursday, August 22, 2024
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
Vandana Singh
Eisai and Biogen's Alzheimer's Drug Leqembi R...
Benzinga Newsdesk
Monday, August 19, 2024
Cracking The Code: Understanding Analyst Reviews For Biogen
Benzinga Insights
Needham Reiterates Buy on Biogen, Maintains $...
Benzinga Newsdesk
Tuesday, August 13, 2024
3 Big Drug Stocks to Watch on Raised 2024 Earnings & Sales View
Zacks
Friday, August 09, 2024
How Is The Market Feeling About Biogen?
Benzinga Insights
Tuesday, August 06, 2024
Mizuho Maintains Outperform on Biogen, Lowers...
Benzinga Newsdesk
Monday, August 05, 2024
Biogen shares are trading lower after Needham...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Biogen, L...
Benzinga Newsdesk
Needham Maintains Buy on Biogen, Lowers Price...
Benzinga Newsdesk
Friday, August 02, 2024
RBC Capital Maintains Outperform on Biogen, R...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Biogen,...
Benzinga Newsdesk
Scotiabank Maintains Sector Outperform on Bio...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Biogen, Lo...
Benzinga Newsdesk
Wedbush Maintains Neutral on Biogen, Lowers P...
Benzinga Newsdesk
Thursday, August 01, 2024
Biogen Q2 Earnings & Sales Beat, 2024 Guidance Raised
Zacks
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
Piero Cingari
Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
Vandana Singh
Biogen Exec Says Believe Ema Concerns For Alz...
Benzinga Newsdesk
Needham Reiterates Buy on Biogen, Maintains $...
Benzinga Newsdesk
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
Shanthi Rexaline
Biogen Expects 2024 Adjusted EPS Of $15.75-$1...
Benzinga Newsdesk
Biogen shares are trading higher following be...
Benzinga Newsdesk
Biogen Q2 2024 Adj. EPS $5.28 Beats $4.03 Est...
Benzinga Newsdesk
Wednesday, July 31, 2024
Alcyone Therapeutics Announces Continued Enro...
Benzinga Newsdesk
Tuesday, July 30, 2024
Biogen shares are trading higher after the co...
Benzinga Newsdesk
Eisai Co. And Biogen Present New Clinical Dat...
Benzinga Newsdesk
Biogen, Beckman Coulter And Fujirebio Announc...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch